The Queen and the Dark Twin: Heme, Protoporphyrin IX, and State Transitions in Liver Metabolism
Molecules · 19.05.2026 · 31 (10) · 1719
DOI: 10.3390/molecules31101719 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 19.05.2026. Verfasst von Swamy R Adapa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global, Environmental, and Genomic Health Sciences, College of Public Health, University of South Florida, Tampa, FL 33612, USA. Hauptthemen laut MEDLINE: Heme, Protoporphyrins, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of South Florida, FLDOH, NIH.
Abstract (Originalsprache)
Heme metabolism in the liver has traditionally been described as a linear pathway that supports oxygen utilization, redox balance, and detoxification. Here, we synthesize recent evidence and propose a framework in which heme functions as a system-level regulator, the “queen” of metabolism, whereas its upstream intermediate protoporphyrin IX (PPIX) represents a chemically reactive “dark twin” that emerges when metabolic flux fails to resolve. In this view, metabolic state is defined not only by end products but also by the behavior of pathway intermediates. This system is spatially organized. Hepatocytes dominate heme synthesis and utilization. In contrast, liver stromal compartments, particularly Kupffer cells, play a central role in heme degradation through heme oxygenase-1 (HMOX1), linking heme turnover to iron recycling and stress adaptation. The metabolic state of the liver therefore reflects not only pathway flux but also the degree of coupling between these cellular compartments. We propose a state model of hepatic heme metabolism. In the resolution state, most evident during inflammation, coordinated hepatocyte–macrophage activity maintains flux and limits intermediate accumulation. In contrast, the expansion state, exemplified in cancer, is defined by impaired flux completion, leading to PPIX accumulation, metabolic heterogeneity, and oxidative stress. This framework reframes liver disease through intermediate behavior rather than pathway presence: porphyrias reflect direct overload, metabolic liver diseases partial expansion, and hepatocellular carcinoma a fully developed expansion state. By focusing on the “intermediate space,” this model links biochemistry, spatial organization, and disease pathogenesis, while suggesting new opportunities for diagnosis and therapy based on metabolic state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global, Environmental, and Genomic Health Sciences, College of Public Health, University of South Florida, Tampa, FL 33612, USA.
- Genomics Program, University of South Florida, Tampa, FL 33612, USA.
ORCID-Profile: Swamy R Adapa, Rays H Y Jiang
Förderung
- University of South Florida
- FLDOH
- NIH
- the USF Provost’s CREATE Award
- the COPH Research Award
- WLP award
- the USF Microbiome Institute Award
Zitieren
APA
Adapa, S. R., & Jiang, R. H. Y. (2026). The Queen and the Dark Twin: Heme, Protoporphyrin IX, and State Transitions in Liver Metabolism. Molecules, 31(10), 1719. https://doi.org/10.3390/molecules31101719
Vancouver
Adapa SR, Jiang RHY. The Queen and the Dark Twin: Heme, Protoporphyrin IX, and State Transitions in Liver Metabolism. Molecules. 2026;31(10):1719. doi:10.3390/molecules31101719
BibTeX
@article{Adapa2026,
author = {Adapa, Swamy R and Jiang, Rays H Y},
title = {The Queen and the Dark Twin: Heme, Protoporphyrin IX, and State Transitions in Liver Metabolism},
journal = {Molecules},
year = {2026},
volume = {31},
number = {10},
pages = {1719},
doi = {10.3390/molecules31101719}
}
EUVIMED